Fount of Information

ACROBiosystems社 Your Warehouse for COVID-19 Research



Products Support Resources Insights About Us

ACROBiosystems, Your Warehouse for COVID-19 Research

A Year in Review


ACROBiosystems, Your Warehouse for COVID-19 Research
Warehouse_for_COVID-19_2.jpg Recently, a new Omicron subvariant, XBB.1.5, is spreading rapidly and is considered by the WHO as the most transmissible variant so far. A new research result determined that XBB.1.5 has a substantially higher hACE2-binding affinity and strong immune evasion capability than previous dominant variants. Therefore, the research of this new variant and the development of effective neutralizing antibodies and vaccines against it is urgently needed. 
Full Product List
Viruses and Vaccines: Two Sides of the Same Coin
‘Prevention is the best medicine’. With the occurrence and subsequent persistence of COVID-19, vaccines have found themselves back in the spotlight with renewed interest. In the post-COVID era, what does this mean for vaccines, and viruses in the future? Dr. Ge, the resident expert for this area at ACROBiosystems has shared her thought about the COVID pandemic and other infectious diseases, as well as the future of vaccines. Warehouse_for_COVID-19_3.jpg
Read the Interview Article

Variant Boosters and Bivalent Vaccines…

Who’s Going to Break the Stalemate with COVID-19?
Warehouse_for_COVID-19_4.jpg Vaccines play an integral role in controlling the spread of SARS-CoV-2. However, as newer, more infectious variants begin to challenge and escape existing immunity, people are becoming increasingly worried about the efficacy of current vaccines. Booster shots are now used to combat diminishing vaccine efficacy; however, a balance needs to be struck between severe illness prevention and the recommended frequency of booster shots. Bivalent and broad-spectrum vaccines are thought as the potential for achieving comprehensive protection.
Check out the Latest Research

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。